How should I accurately document a negative tuberculosis test result?

Documentation of Negative Tuberculosis Test Results

When documenting a negative TB test, you must record the specific test type (TST or IGRA), the exact measurement in millimeters for TST, the date performed, the date read, and critically—the patient's risk category that determined the cutoff used for interpretation. 1

Essential Documentation Elements

For Tuberculin Skin Test (TST)

• Exact induration measurement in millimeters (not just "negative" or "positive") 2
• Date and time of placement and date and time of reading (must be read 48-72 hours after placement) 2
• Site of placement (typically forearm) 2
• Lot number and expiration date of tuberculin used 2
• Person who administered the test and person who read the test 2

Critical Risk Stratification Documentation

The interpretation of "negative" depends entirely on the patient's risk category, which must be documented 1:

• For high-risk patients (HIV+, immunosuppressed, recent TB contact, abnormal chest X-ray): Document that <5 mm is negative 1
• For moderate-risk patients (healthcare workers, immigrants from endemic areas, injection drug users, diabetes, chronic renal failure, residents of congregate settings): Document that <10 mm is negative 1
• For low-risk patients (no known risk factors): Document that <15 mm is negative 1

For IGRA Testing

• Specific test name (QuantiFERON-TB Gold or T-SPOT.TB) 3, 4
• Exact quantitative result (not just positive/negative) 3
• Date of blood draw and date processed (must be within 12 hours for QuantiFERON) 3
• Laboratory performing the test 3

Special Documentation Scenarios

Two-Step Testing for Healthcare Workers

When performing baseline two-step testing for newly employed healthcare workers 2:

• Document the first TST result with exact measurement
• If negative, document second TST performed 1-3 weeks later with exact measurement 2
• If second test is positive, document as "boosted reaction, classified as previously infected" (not a new conversion) 2
• If second test remains negative, document as "uninfected at baseline" 2

Window Period Testing After Exposure

For contacts of active TB cases 5:

• Document initial test performed with date relative to last exposure
• If initial test is negative and performed <8 weeks after exposure, document "negative test unreliable for excluding infection due to window period" 5
• Document repeat test scheduled for 8-10 weeks post-exposure 5
• For high-risk contacts (children <5 years, immunocompromised), document initiation of window prophylaxis despite negative test 5

Immunocompromised Patients

For patients on immunosuppressive therapy, with HIV, or other immunocompromising conditions 1:

• Document the specific immunocompromising condition
• Note that negative tests may be falsely negative due to anergy 1
• Consider documenting chest radiograph results even with negative test, as this is often required in endemic regions 1
• If anergy testing performed (controversial and not routinely recommended), document specific antigens used and results 1

Common Documentation Pitfalls to Avoid

Never Document Only "Negative" Without Context

A simple "negative TB test" is inadequate and potentially dangerous 1. The same 8mm induration is:

• Positive in an HIV+ patient (cutoff 5mm) 1
• Negative in a healthcare worker (cutoff 10mm) 1
• Negative in a low-risk patient (cutoff 15mm) 1

BCG Vaccination History

• Document BCG vaccination history but interpret results based on risk factors, not BCG status 2
• A reaction ≥10mm in an adult vaccinated as a child from a high-prevalence country should be attributed to M. tuberculosis infection, not BCG 2
• Do not dismiss positive results as "just BCG" without considering epidemiologic factors 2

Serial Testing Documentation

For healthcare workers or others undergoing serial testing 2:

• Document baseline result clearly to allow comparison
• For conversions, document previous result, current result, and time interval 2
• Standard conversion definition: ≥10mm increase within 2 years, but in contact investigations, any change from negative to positive (using 5mm cutoff) should be documented as a change in tuberculin status 5

False-Negative Considerations

Document factors that may cause false-negative results 1, 6, 7:

• Recent TB infection (within 8-10 weeks—window period) 5
• Severe or disseminated TB disease (23% of TB patients have negative tests; up to 64% with disseminated disease) 6
• Age >60 years (27% negative in ages 60-74; 44% in ages >74) 6
• HIV infection (61% negative) 6
• Immunosuppressive therapy (50% negative) 6
• Technical errors in administration or reading 1, 7

When Negative Test Requires Additional Action

Document the following clinical decisions based on negative results:

Repeat Testing Indicated

• Immunocompromised patients with high clinical suspicion: Consider repeating TST on opposite arm within 5 weeks or using IGRA as confirmatory test 1, 4
• Recent exposure (<8 weeks): Schedule repeat test at 8-10 weeks post-exposure 5
• Healthcare workers at baseline: Perform two-step testing if no documented negative test in past 12 months 2

Chest Radiograph Despite Negative Test

Document chest X-ray results when obtained despite negative test 1:

• High-risk patients (HIV+, immunosuppressed, endemic area residents) 1
• Patients with TB symptoms regardless of test results 2
• Contacts of smear-positive cases 5

Presumptive Treatment Despite Negative Test

Document rationale for treatment when initiated despite negative test 5:

• Children <5 years exposed to active TB: Window prophylaxis after excluding active disease 5
• Severely immunocompromised contacts: Full treatment course even with negative test at 8-10 weeks if transmission rate to other contacts was high 5

Algorithm for Complete Documentation

1. Record exact measurement/result with units 2, 3
2. Document patient risk category that determined interpretation cutoff 1
3. Note timing relative to exposure if applicable 5
4. List immunocompromising conditions if present 1, 6
5. Document BCG history but don't let it override risk-based interpretation 2
6. Record follow-up plan: repeat testing, chest X-ray, or clinical monitoring 1, 5
7. Note if two-step testing was performed for healthcare workers 2